PAH diagnosis may be delayed in patients with CHD1
Symptom recognition to diagnosis in patients with PAH-CHD1*






Screening for PAH may help diagnose patients sooner and improve long-term outcomes2-7
In a registry of 360 adults with PAH-CHD, there was, on average, a 6-year delay from symptom recognition to PAH presentation and diagnosis
The mean age of first symptom onset was 24.6 ± 16.5 years, while diagnosis was confirmed at a mean age of 31.2 ± 14 years
Screening for PAH may help diagnose patients sooner and improve long-term outcomes2-7